Prognosis of Cerebral Small Vessel Disease

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age16+
SponsorInsel Gruppe AG, University Hospital Bern

About this trial

Prognosis of small vessel disease (SVD) depends on the underlying type of SVD and index manifestation.

The aim of this prospective, observational cohort study is to determine the risk of different outcome events among patients with SVD according to the type of index presentation.

Eligibility criteria

Qualifiers

Hypertensive deep perforator arteriolopathy (DPA), clinically symptomatic with either ICH, ischaemic stroke, cognitive impairment or severe radiological manifestation (Fazekas ≥II)

Cerebral amyloid angiopathy (CAA according to modified Boston or Edinburgh criteria), clinically symptomatic with either ICH (including cSAH), amyloid spells, cognitive impairment or severe radiological manifestation (CMB≥2)

Other SVD (i.e. CADASIL or other sporadic or genetic SVD)

Disqualifiers

Life expectancy of <6 months due to not-SVD related causes (i.e. cancer)

Patient is unlikely to attend follow-up visits

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed